Socialization

CultureBot Unveils Innovative Solution to Combat Silent Quitting in Remote Work with "AI Water Cooler"

Retrieved on: 
Monday, November 20, 2023
Emotional intelligence, News, AI, Socialization, Sport, Organization, Communication, Dairy

In an era defined by remote work and "silent quitting", CultureBot is excited to announce the launch of its most effective team building solution to date - "AI Water Cooler".

Key Points: 
  • This groundbreaking addition to the popular Slack application is poised to tackle the pervasive issue of silent quitting, redefining how remote teams engage, collaborate, and thrive.
  • Silent quitting, the phenomenon where employees disengage and withdraw from their work without overtly expressing dissatisfaction, has become a growing concern in the remote work environment.
  • The "AI Water Cooler" feature is not just a tool; it is a strategic intervention designed to foster a sense of community, connection, and camaraderie among remote teams.
  • CultureBot's AI Water Cooler is not just a tool; it's a manifestation of the company's commitment to creating a positive and inclusive remote work environment.

National Academy of Sports Medicine® Premieres Mindful Drinking as its Latest Wellness Course

Retrieved on: 
Tuesday, December 12, 2023
Mindfulness, Culture, Food, Nova Southeastern University, Proxemics, Drinking, USA Today, NSU, Health, Imbibe, National academy, Socialization, Health coaching, Sleep, Social media, Overalls, NASM, Sports medicine, Generation Z, Esquire, Interior design

The mindful drinking movement is trending - fueled primarily by Gen Z, who in 2022 was the fastest growing demographic of non-alcoholic-drink consumers.

Key Points: 
  • The mindful drinking movement is trending - fueled primarily by Gen Z, who in 2022 was the fastest growing demographic of non-alcoholic-drink consumers.
  • This mindful drinking trend, amplified by social media influencers, has contributed to the popularity of increasingly sophisticated no and low alcohol cocktails.
  • “The end goal of the Mindful Drinking course is to empower people with strategies for making choices and changes related to drinking alcohol,” said Brown.
  • To explore NASM’s Mindful Drinking course and what you can expect to learn, visit: www.nasm.org/mindfuldrinking

Trupanion, leading pet medical insurance provider, teams up with renowned animal health experts to raise awareness around pet behavioral health

Retrieved on: 
Thursday, December 7, 2023
Pet, Create, Fear, Adolescence, Cat, Research, Diarrhea, Parent, Trupanion, Health, Doctor of Philosophy, Dog, Anxiety, Sneeze, Socialization, Behavior, Cough, Appetite, CLAS, Veterinary medicine, MRCVS, CVA, Neuroscience, Vomiting, Behavior informatics, Neuro, Environment, Pet industry

The timing of this Trupanion-hosted event coincides with rising veterinary visits related to behavioral concerns in pets.

Key Points: 
  • The timing of this Trupanion-hosted event coincides with rising veterinary visits related to behavioral concerns in pets.
  • During the live event, pet parents received invaluable guidance on enhancing their pets' well-being by understanding and addressing behavioral issues.
  • Here, we share five key takeaways from the event to help pet parents better manage the behavioral health of their beloved furry companions:
    Recognize your pet's normal behavior.
  • Trupanion's Chief Veterinary Officer, Dr. Steve Weinrauch and our panel of animal health experts, are available to share related insights and tips into managing pet behavioral health.

Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis

Retrieved on: 
Wednesday, December 6, 2023
Drooling, Quality of life, Cat, Pet, FDA, B cell, Weight loss, Regenerative medicine, Disease, JEDI, SAN, Mouth, Therapy, DVM, Socialization, FCGS, Death, Veterinary medicine, SVP, Gallant, Safety, Argyreia nervosa

SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Gallant Therapeutics, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced the launch of a pivotal study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis (FCGS), the JEDI study.

Key Points: 
  • SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Gallant Therapeutics , an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced the launch of a pivotal study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis (FCGS), the JEDI study .
  • More than 50% of these cats do not respond to therapy (are refractory) and are euthanized or die.
  • In pilot studies1, Gallant’s investigational stem cell therapy has been demonstrated effective for refractory FCGS, improving painful lesions and quality of life, allowing these cats to live longer and healthier lives.
  • The multicenter pivotal JEDI study includes veterinary dental specialist sites across the United States and is currently enrolling cats under an FDA-concurred protocol.

ABS Kids Opens Its 31st ABA Therapy Center in the U.S., Supporting Increasing Need for Children and Families With Autism Spectrum Disorder

Retrieved on: 
Tuesday, December 19, 2023
General Health, Health, Other Education, Children, Family, Consumer, Education, Other Health, Autism spectrum, Partnership, Learning, Multimedia, Spectrum, Physician, BCBA, ASD, Disability studies, ABA, Socialization, Social skills, ABS, LBA, Diagnosis, Toy

In total, ABS Kids has 31 ABA therapy centers and early autism diagnosis clinics to support families across California, North Carolina, Tennessee and Utah.

Key Points: 
  • In total, ABS Kids has 31 ABA therapy centers and early autism diagnosis clinics to support families across California, North Carolina, Tennessee and Utah.
  • View the full release here: https://www.businesswire.com/news/home/20231219816544/en/
    Each one of ABS Kids’ centers feature themed rooms for specific skill development, socialization and sensory control.
  • ABS Kids has 31 applied behavioral analysis (ABA) therapy centers and autism diagnosis clinics to support families across California, North Carolina, Tennessee and Utah.
  • “ABS Kids advocates for the autism community and we’re working to bring more care options to help families and children affected by ASD,” said ABS Kids CEO Adam Singer , M.D.

Take Your Pup for a Day of Play at Two New Dogtopias in Houston

Retrieved on: 
Tuesday, December 19, 2023
Veteran, Pet, Partnership, Student, Joint, Amber, Parent, Drive, Education, Football, Spectrum, Dog, Animal, Socialization, Love, Social skills, Growth, Safety, Table tennis rubber, Organization, Exercise

HOUSTON, Dec. 19, 2023 /PRNewswire/ -- Dogtopia, the nation's leading dog wellness brand, is excited to announce the expansion of their presence in Houston with the opening of two new locations inside the loop. The first facility, located at 1315 Waugh Dr., has been a part of the Houston community for some time and reopened with all new facilities and increased capacity on December 18. The second location, situated at 2311 Washington Ave., is scheduled to open in mid-January. In addition to the three Dogtopias currently open in Houston, the two new locations will offer award-winning daycare, overnight, and spa services to even more dog parents in the area.

Key Points: 
  • In addition to the three Dogtopias currently open in Houston, the two new locations will offer award-winning daycare, overnight, and spa services to even more dog parents in the area.
  • Dogtopia allows dogs to enjoy plenty of exercise, play with like-minded dogs, and learn important social skills, all under the supervision of professionally trained Canine Coaches.
  • The two new establishments are under the ownership of Amber Woods, a dedicated local entrepreneur with a deep love for dogs.
  • Dogtopia of Houston – Washington Ave. is open Monday through Friday from 6:30 a.m. to 7:30 p.m., Saturday from 9:00 a.m. to 5:00 p.m.

CMS Funded Study Shows Great Promise for Indiana-Based American Senior Communities

Retrieved on: 
Tuesday, December 19, 2023
AT&T, Quality of life, Music, Travel, Pet, Partnership, Caregiver, Loneliness, Depression, ASC, Health, Stanford University, HTC, Meditation, VIVE, Socialization, Ageing, Virtual Human Interaction Lab, Therapy, Nature, CMS

INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ -- Indiana-Based American Senior Communities has partnered with Mynd Immersive (formerly MyndVR) to operationalize a new and innovative way to address isolation and loneliness among their aging residents. The CMS-funded program began in August of 2023 at 15 skilled nursing facilities across the state of Indiana with the main goal of improving overall quality of life, namely by addressing feelings of isolation, a key element of loneliness and depression among older adults, and increased socialization by a minimum of 60% improvement.

Key Points: 
  • INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ -- Indiana-Based American Senior Communities has partnered with Mynd Immersive (formerly MyndVR) to operationalize a new and innovative way to address isolation and loneliness among their aging residents.
  • The initial outcomes reported to CMS and the Indiana Department of Health included a total of 660 respondents, most of whom had an overwhelmingly positive experience.
  • "Mynd Immersive has demonstrated significant benefits for our staff and residents, and we are grateful to have participated in Mynd's endeavors to validate these advantages."
  • "Through this partnership with ASC, our teams are also proving that deploying Mynd across multiple communities with trained staff can be done quickly and cost-effectively."

Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder

Retrieved on: 
Monday, November 20, 2023
ASD, Yamo, Food, Socialization, Social, Spectrum, Patient, FDA, MD, Communication, Doctor of Philosophy, Fast Track, Aircraft, Pharmaceutical industry

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals LLC (Yamo), a clinical stage pharmaceutical company, announced today that it has completed enrollment in its Phase 2 study evaluating L1-79 in adolescents and young adults with autism spectrum disorder (ASD).

Key Points: 
  • NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals LLC (Yamo), a clinical stage pharmaceutical company, announced today that it has completed enrollment in its Phase 2 study evaluating L1-79 in adolescents and young adults with autism spectrum disorder (ASD).
  • With the completion of Phase 2 enrollment, Yamo has initiated a Phase 3 readiness program to optimize L1-79’s development timeline.
  • L1-79 is a tyrosine hydroxylase inhibitor designed to improve the core socialization and communication symptoms of ASD by modulating the catecholaminergic pathways implicated in ASD.
  • In 2018, Yamo received Fast Track designation for L1-79 from the Food and Drug Administration (FDA) based on the promising results of its Phase 2a study.

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Retrieved on: 
Tuesday, November 14, 2023
CNS, Webcast, Principal, ID, Associate, Gait, Safety, Pediatrics, Gene, Silicon Valley Bank, Socialization, Phenotype, Disease, Risk, Clinical trial, CHU, Administration, Patient, Cell, Dysrhythmia, FAAP, Research, ESGCT, Movement, Posture, Seizure, Hyperventilation, Development, IDMC, FRCP, Rett syndrome, Congress, Central nervous system, Mutation, Walking, Șaeș, AAV, MECP2, Pharmaceutical industry, Nursing, Vaccine, Cryptocurrency, Rett, DALLAS, Neuroscience

Following treatment, both patients experienced improvement in key clinical domains impacting activities of daily living, including breathing dysrhythmia, autonomic function, socialization, and gross and fine motor skills.

Key Points: 
  • Following treatment, both patients experienced improvement in key clinical domains impacting activities of daily living, including breathing dysrhythmia, autonomic function, socialization, and gross and fine motor skills.
  • Additional information on available clinical data is available in the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2023, to be filed with the SEC.
  • Cash and cash equivalents: As of September 30, 2023, the Company had cash and cash equivalents of $164.3 million.
  • Taysha management will hold a conference call and webcast today at 4:30 pm ET to review its financial and operating results and to provide corporate and clinical updates.

Pennsylvania LIFE Provider Alliance (PALPA) Advocates for Enhanced Seniors' Quality of Life Through LIFE Program

Retrieved on: 
Thursday, December 14, 2023
Public Policy, Government, Seniors, Managed Care, General Health, Health, Healthcare Reform, Consumer, Advocacy Group Opinion, Safety, Senior, Hope, Nursing, Socialization, Social isolation, PACE, Ageing, Community, Education, Quality of life, Transport, Health insurance

The Pennsylvania LIFE Provider Alliance (PALPA) continues taking proactive steps to promote the significance of the Living Independence For the Elderly (LIFE) program in enhancing the quality of life for seniors across Pennsylvania.

Key Points: 
  • The Pennsylvania LIFE Provider Alliance (PALPA) continues taking proactive steps to promote the significance of the Living Independence For the Elderly (LIFE) program in enhancing the quality of life for seniors across Pennsylvania.
  • By providing in-home assistance, transportation, personal care, social contact, and nursing care, the LIFE program acts as a safety net for America’s seniors.
  • PALPA is comprised of seven LIFE providers, LIFE NWPA , LIFE Geisinger , Community LIFE , LIFE Pittsburgh , Lutheran Senior LIFE , Albright Care Services and Mercy LIFE , representing 40 LIFE centers operating across 44 counties.
  • Richard Fish, President of the board of the Pennsylvania LIFE Provider Alliance and CEO of LIFE NWPA , a leading PACE provider, emphasizes the transformative impact of the LIFE program.